Carderock Capital Management’s Eli Lilly LLY Stock Holding History

Carderock Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.4M	Buy	12,818 +236	+2%	+$241K	3.37%	4
2026 Q1	$11.6M	Buy	12,582 +398	+3%	+$403K	2.86%	7
2025 Q4	$13.1M	Buy	12,184 +1,022	+9%	+$977K	3.17%	5
2025 Q3	$8.52M	Buy	11,162 +121	+1%	+$90K	2.07%	17
2025 Q2	$8.61M	Buy	11,041 +1,581	+17%	+$1.23M	2.2%	18
2025 Q1	$7.81M	Buy	9,460 +1,337	+16%	+$1.11M	2.07%	24
2024 Q4	$6.27M	Sell	8,123 -848	-9%	-$702K	1.57%	36
2024 Q3	$7.95M	Buy	8,971 +1,206	+16%	+$1.08M	1.88%	25
2024 Q2	$7.03M	Buy	+7,765	New	+$6.21M	1.84%	30
2023 Q2	–	Sell	-185	Closed	-$63.5K	–	90
2023 Q1	$63.5K	Buy	+185	New	+$62.4K	0.02%	93

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Carderock Capital Management's LLY Position: Q2 2026 in Review

Carderock Capital Management increased its Eli Lilly (LLY) stake by 1.9% in Q2 2026, buying an estimated $241K and bringing the position to 12,818 shares worth $15.4M. The position accounts for 3.37% of the portfolio, ranked #4.

Carderock Capital Management first reported a position in LLY in Q1 2023 and has held it in 10 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Carderock Capital Management held 12,818 shares of Eli Lilly worth $15.4M as of Q2 2026.
Carderock Capital Management bought 236 Eli Lilly shares in Q2 2026, an estimated $241K.
Eli Lilly made up 3.37% of Carderock Capital Management's portfolio in Q2 2026, its #4 holding.
Carderock Capital Management first reported a position in Eli Lilly in Q1 2023 and has held it in 10 quarters since.
2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Carderock Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.